Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Expense and benefit of neoadjuvant treatment in squamous cell carcinoma of the esophagus ; volume:1 ; number:1 ; day:23 ; month:11 ; year:2001 ; pages:1-6 ; date:12.2001
BMC cancer ; 1, Heft 1 (23.11.2001), 1-6, 12.2001
- Creator
-
Heise, Joachim W.
- Contributor
-
Heep, Hansjörg
Frieling, Thomas
Sarbia, Mario
Hartmann, Karl A.
Röher, Hans-Dietrich
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-1-20
- URN
-
urn:nbn:de:1111-2016030336323
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heise, Joachim W.
- Heep, Hansjörg
- Frieling, Thomas
- Sarbia, Mario
- Hartmann, Karl A.
- Röher, Hans-Dietrich
- SpringerLink (Online service)
Other Objects (12)
Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
Epidemiological Review: Esophagus Squamous Cell Carcinoma in India
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Expense huius Misse.
Approach to Localized Squamous Cell Cancer of the Esophagus
Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Alterations of RNA splicing patterns in esophagus squamous cell carcinoma
Plummer-Vinson syndrome presenting as squamous cell carcinoma of esophagus
Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
Epidemiological Review: Esophagus Squamous Cell Carcinoma in India
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Expense huius Misse.
Approach to Localized Squamous Cell Cancer of the Esophagus
Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Alterations of RNA splicing patterns in esophagus squamous cell carcinoma
Plummer-Vinson syndrome presenting as squamous cell carcinoma of esophagus
Neoadjuvant strategies in resectable carcinoma esophagus: a meta-analysis of randomized trials
Neoadjuvant versus definitive chemoradiation in patients with squamous cell carcinoma of the esophagus
Epidemiological Review: Esophagus Squamous Cell Carcinoma in India
MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Expense huius Misse.
Approach to Localized Squamous Cell Cancer of the Esophagus
Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinoma or squamous cell carcinoma of the esophagus (CROSS)
Significance of Neoadjuvant Downstaging in Carcinoma of Esophagus and Gastroesophageal Junction
Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
Alterations of RNA splicing patterns in esophagus squamous cell carcinoma
Plummer-Vinson syndrome presenting as squamous cell carcinoma of esophagus